Inflammatory markers in spinal fluid can reflect patients’ cognitive status
Inflammatory biomarkers in the cerebrospinal fluid (CSF) of Parkinson’s disease patients with and without mutations in the GBA gene are…
Articles by Steve Bryson, PhD
Gains seen in Parkinson’s with Symbyx’s red light therapy helmet
Symbyx Neuro, Symbyx Biome’s red/infrared light therapy helmet, improves motor function in Parkinson’s disease, according to data from…
$400K award will go to explore brain-gut connection in Parkinson’s
The U.S. Department of Defense has awarded $400,000 to an Augusta University (AU) neuroscientist to research a possible brain-gut connection…
Genetics study in Black, African American people expands
The Black and African American Connections to Parkinson’s Disease (BLAAC PD) study, a research effort to understand the genetic…
Brain’s recycling system is blocked by mutation tied to Parkinson’s
A mutation in the SH3GL2 gene that’s associated with an increased risk of Parkinson’s disease contributes to a buildup…
Potential dementia therapy, NYX-458, fails in Phase 2 Parkinson’s trial
Aptinyx’s investigational therapy NYX-458 failed to be superior to a placebo at improving cognitive function in people with…
Fine particle air pollution tied to Parkinson’s risk in US study
People living in areas with high levels of an air pollutant called fine particulate matter (PM2.5) — whose sources include…
How genetics and environment are likely to cause Parkinson’s detailed
Using a roundworm animal model, researchers identified a crucial mechanism for how signals from the environment can be combined with…
Proteostasis regulators are potential Parkinson’s targets, biomarkers
Certain regulators of protein balance are suppressed in people with sporadic Parkinson’s disease and in those with familial…
MJFF awards $2.5M grant for Parkinson’s app Soturi
The Michael J. Fox Foundation for Parkinson’s Research (MJFF) has awarded a $2.5 million research grant to advance the…